Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionHuman fibrinogen and thrombin hemostatic surgical patch
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices
Latest Stage of DevelopmentMarketed
Standard IndicationBleeding
Indication DetailsImprove hemostasis; Prevent postoperative cerebrospinal leakage following neurological surgery; Prevent mild to moderate bleeding from small blood vessels in cardiovascular surgery
Regulatory Designation
PartnerBaxter International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today